alexa Calciphylaxis: Current Management and Emerging Therapie
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Special Issue Article

Calciphylaxis: Current Management and Emerging Therapies

Eleftheriadis T1, Leivaditis K2, Antoniadi G2 and Liakopoulos V2*

1Department of Nephrology, Medical School, University of Thessaly, University Hospital of Larissa, Larissa, Greece

2Division of Nephrology, 1st Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece

*Corresponding Author:
Vassilios Liakopoulos
Assistant Professor of Nephrology, Division of Nephrology
1st Department of Internal Medicine, Medical School
Aristotle University of Thessaloniki, AHEPA Hospital
1 S. Kyriakidi street, 54634, Thessaloniki, Greece
Tel: +302310994694
Fax: +302310994694
E-mail: [email protected]

Received Date: November 15, 2011; Accepted Date: January 04, 2012; Published Date: January 06, 2012

Citation: Eleftheriadis T, Leivaditis K, Antoniadi G, Liakopoulos V (2012) Calciphylaxis: Current Management and Emerging Therapies. J Nephrol Therapeutic S1:001. doi: 10.4172/2161-0959.S1-001

Copyright: © 2012 Eleftheriadis T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Calciphylaxis or calcific uremic arteriolopathy is a relatively uncommon condition with poor prognosis. Although it is predominantly observed in patients with end stage renal disease, a few cases of patients without kidney failure have been reported. Calciphylaxis is characterized by calcification of the arteriolar intima media and eventually by vascular thrombosis, tissue ischemia and painful skin necrosis. Septicemia is the main cause of death. According to published literature concerning the pathology of calciphylaxis, prevention and treatment are principally based on interventions in calcium and phosphorus metabolism. Although novel therapies have emerged, due to the rarity of this condition, there is no sufficient data in favor of a certain treatment.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version